USPTO Affirms Abbott Protein Patent In War With Yeda

By Samuel Howard (May 27, 2010, 1:59 PM EDT) -- Abbott GmbH & Co. KG has cemented its victory in a 14-year-old dispute with Yeda Research & Development Co. Ltd. over a patent for a tumor necrosis factor protein, winning recognition that one of its patent applications is the earliest reference to the protein, which is used in autoimmune therapies....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!